文献速递心胸血管麻醉

体外循环期间及非体外循环期间术中低血压与急性肾损伤、卒中和死亡的关系:一项回顾性观察队列研究

Intraoperative Hypotension and Acute Kidney Injury, Stroke, and Mortality during and outside Cardiopulmonary Bypass: A Retrospective Observational Cohort Study.
PubMed 文献 · Anesthesiology · 2022-01-01

该回顾性观察队列研究纳入2008至2016年间一家三级医院接受心脏手术的成人患者4984例,术中低血压定义为平均动脉压低于65 mmHg。主要复合结局为住院期间卒中、急性肾损伤或死亡,发生率为5.1%。研究显示,整个手术期间低血压总时长及体外循环外低血压时长与复合结局风险增加相关,而体外循环期间低血压时长占比低于60%亦与风险增加相关。

要点

  • 术中平均动脉压低于65 mmHg的总时长与心脏手术后卒中、急性肾损伤或死亡复合结局风险增加相关。
  • 体外循环外低血压每10分钟暴露与复合结局风险增加独立相关。
  • 体外循环期间低血压时长占比低于60%与复合结局风险增加相关,而单纯体外循环内低血压时长无显著关联。

核心结论

  • 心脏手术中术中低血压与术后急性肾损伤、卒中或死亡复合结局风险增加相关,尤其是体外循环外低血压及体外循环期间低血压占比较低时。

研究设计与样本

  • 回顾性观察队列研究,纳入2008至2016年一家三级医院接受心脏手术的成人患者4984例。

主要发现

  • 复合结局发生于4984例中的256例(5.1%),其中卒中66例(1.3%)、急性肾损伤125例(2.5%)、死亡109例(2.2%)。
  • 整个手术期间低血压总时长与复合结局相关(校正比值比1.05;95%CI 1.02至1.08;P=0.032)。
  • 体外循环外每10分钟平均动脉压低于65 mmHg与复合结局相关(校正比值比1.06;95%CI 1.03至1.10;P=0.001)。
  • 体外循环期间低血压时长占比低于60%与复合结局相关(参照组大于80%;校正比值比1.67;95%CI 1.10至2.60;P=0.019)。
  • 体外循环期间每10分钟低血压、体外循环期间低血压占比60%至80%、总血管升压药-正性肌力药剂量与复合结局无显著关联。

关键数值与推荐

  • 术中低血压定义为平均动脉压低于65 mmHg。
  • 主要复合结局为住院期间卒中、急性肾损伤或死亡。
  • 低血压总时长按体外循环期间低血压时长占比分为大于80%、80%至60%、低于60%三类。

临床怎么用

  • 心脏手术围术期应关注平均动脉压低于65 mmHg的持续时间,尤其需重视体外循环外低血压的管理。

局限性

  • 本研究为单中心回顾性观察性研究,结论需进一步多中心研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In cardiac surgery, the association between hypotension during specific intraoperative phases or vasopressor-inotropes with adverse outcomes remains unclear. This study's hypothesis was that intraoperative hypotension duration throughout the surgery or when separated into hypotension during and outside cardiopulmonary bypass may be associated with postoperative major adverse events. METHODS: This retrospective observational cohort study included data for adults who had cardiac surgery between 2008 and 2016 in a tertiary hospital. Intraoperative hypotension was defined as mean arterial pressure of less than 65 mmHg. The total duration of hypotension was divided into three categories based on the fraction of overall hypotension duration that occurred during cardiopulmonary bypass (more than 80%, 80 to 60%, and less than 60%). The primary outcome was a composite of stroke, acute kidney injury, or mortality during the index hospitalization. The association with the composite outcome was evaluated for duration of hypotension during the entire surgery, outside cardiopulmonary bypass, and during cardiopulmonary bypass and the fraction of hypotension during cardiopulmonary bypass adjusting for vasopressor-inotrope dose, milrinone dose, patient, and surgical factors. RESULTS: The composite outcome occurred in 256 (5.1%) of 4,984 included patient records; 66 (1.3%) patients suffered stroke, 125 (2.5%) had acute kidney injury, and 109 (2.2%) died. The primary outcome was associated with total duration of hypotension (adjusted odds ratio, 1.05; 95% CI, 1.02 to 1.08; P = 0.032), hypotension outside cardiopulmonary bypass (adjusted odds ratio, 1.06; 95% CI, 1.03 to 1.10; P = 0.001) per 10-min exposure to mean arterial pressure of less than 65 mmHg, and fraction of hypotension duration during cardiopulmonary bypass of less than 60% (reference greater than 80%; adjusted odds ratio, 1.67; 95% CI, 1.10 to 2.60; P = 0.019) but not with each 10-min period hypotension during cardiopulmonary bypass (adjusted odds ratio, 1.04; 95% CI, 0.99 to 1.09; P = 0.118), fraction of hypotension during cardiopulmonary bypass of 60 to 80% (adjusted odds ratio, 1.45; 95% CI, 0.97 to 2.23; P = 0.082), or total vasopressor-inotrope dose (adjusted odds ratio, 1.00; 95% CI, 1.00 to 1.00; P = 0.247). CONCLUSIONS: This study confirms previous single-center findings that intraoperative hypotension throughout cardiac surgery is associated with an increased risk of acute kidney injury, mortality, or stroke.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. de la Hoz MA, Rangasamy V, Bastos AB, et al. Intraoperative Hypotension and Acute Kidney Injury, Stroke, and Mortality during and outside Cardiopulmonary Bypass: A Retrospective Observational Cohort Study. Anesthesiology. 2022. PMID: 35188970. doi:10.1097/ALN.0000000000004175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。